GSK199

Overview

GSK199 is an orally active, reversible, and selective PAD4 inhibitor with an IC 50 of 200 nM in the absence of calcium. GSK199 can be used for the research of rheumatoid arthritis.

Application

Products | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Protein Arginine Deiminase

Product Information

• Catalog No.: HY-103058
• CAS No.: 1549811-53-1
• Molecular Formula: C24H29ClN6O2
• Molecular Weight: 468.98
• Purity: 99.85%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (5.33 mM); Clear solution
• Availability: In-stock

Source

Original product source